Analyst Price Targets — NHP
Latest News for NHP
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics
National Healthcare Properties (NASDAQ: NHP) reported second-quarter results marked by continued growth in its senior housing operating portfolio, an expanded acquisition pipeline and lower leverage following its April initial public offering. Chief Executive Officer Michael Anderson said the company's strategy remains focused on growing its senior housing operating portfolio, or SHOP, through acquisitions,…
National Healthcare Properties NASDAQ: NHP reported second-quarter results marked by continued growth in its senior housing operating portfolio, an expanded acquisition pipeline and lower leverage following its April initial public offering.
National Healthcare Properties, Inc. (NHP) Q2 2026 Earnings Call Transcript
NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (the “Company”) (Nasdaq: NHP) announced today that it will redeem all of the outstanding (i) 3,289,061 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (CUSIP: 42226B204) (the “Series A Preferred Stock”) and (ii) 2,850,427 shares of its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (CUSIP:…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NHP.
U.S. House Trading
No House trades found for NHP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.